A/H5 inactivated monovalent influenza vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for A/H5 inactivated monovalent influenza vaccine, covering 2026-01-09 to 2026-07-23. Get the full timeline:
Most recent: Clinical Trial Results: Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59 [Phase 2]